Have Investors Soured on Lemonade?
Lemonade has a long way to go, but if the stock dips too low based on all of this negativity, I would not be against starting a smaller position with a long-term outlook. 
By Mike Sakuraba | 1 week ago

Should you buy NIO ahead of its earnings report?
Long-term NIO investors really do not have much to complain about as the stock has already returned over 560% year to date.
By Mike Sakuraba | 1 week ago

Has AMWELL gone too high too fast?
Like many tech companies, AMWL has grown at an exponential rate while remaining unprofitable. Is there a path to profitability? Sure.
By Mike Sakuraba | 1 week ago

Pinned photos and  cheaper ads
Despite the impressive growth, the current model does not allow the company to generate even remotely similar revenues abroad compared to its domestic market. In Q2, 2020, the average quarterly revenue per user was $0.14 for international vs. $2.5 for the US based users.  
By Valdas S. | 1 week ago

What Will GameStop look like in the Future?
At its current prices you could do worse than taking a shot on a long-term outlook for GameStop.
By Mike Sakuraba | 3 weeks ago

Yoga pants and smart mirrors
The international operations' primary growth was $159,366 million quarter ending August 2, 2020, vs. $115,904 million in the quarter ending August 4, 2019.
By Valdas S. | 3 weeks ago

What Investors Can Expect from Prime Day
Annually, Prime Day is the biggest event of the year for Amazon and one of the biggest for the retail industry in general. In 2019, Prime Day provided the company with $7 billion in sales from over 175 million items sold worldwide.
By Mike Sakuraba | 3 weeks ago

Christmas may come early this year for Micron Technology
While short term outlook for global economy stays bleak, Micron Technologies are in a unique position to weather through it unscathed.
By Valdas S. | 3 weeks ago

Can Etsy Craft a Rebound?
Some may attribute Etsy’s recent success to the coronavirus quarantine where everyone is staying inside of their homes and buying the things they need online.
By Mike Sakuraba | 4 weeks ago

Could NVAX Have the Winning Vaccine?
Novavax announced that it would officially be entering Phase 3 of its COVID-19 vaccine candidate clinical trials in the U.K., with plans to begin in the United States by the end of October.
By Mike Sakuraba | 4 weeks ago